LRRK2 and Lewy body dementia: In 2021, Brockmann et al. (2021) utilized CSF from a group of patients with clinically diagnosed sporadic PD/DLB and familial PD/DLB patients with different mutations such as GBA(PD/DLB) and LRRK2(PD).